Home  /  About us   /  A history of innovation

A history of innovation

Pushing the boundaries

With a history spanning more than two decades, XVIVO’s journey began in 1998 when founder Dr. Magnus Nilsson acquired the rights to PERFADEX®, the gold standard in lung transplant preservation. Since then, XVIVO has been at the forefront of medical advancements in transplantation medicine, equipping leading clinicians and researchers to push the boundaries of their field.

Timeline

Avionord logo 2022
2022

Acquisition of Avionord Machines & Perfusion, our former Italian distributor.

2022

Kidney Assist Transport (2nd gen) CE marked and FDA 510(k) cleared.

StarTeams logo 2021
2021

Acquisition of Star Teams. An organ recovery company serving the U.S. market.

2020

Acquisition of Organ Assist XVIVO becomes the first all organ company.

2018

PERFADEX® Plus. FDA 510(k) cleared and CE marked.

2017

First heart transplant using a preservation technique developed by XVIVO partner Prof. Stig Steen.

2015

Kidney Assist CE marked.

2014

XPS™ approved by FDA under HDE in the US. CE marked on the EU market.

2010/2013

Kidney Assist Transport (1st gen) / Liver Assist CE marked

2006

STEEN Solution™  CE marked.

2001

PERFADEX® FDA 510(k) cleared.

2000

The first EVLP lung transplant performed with STEEN Solution™.

1999

Organ Assist founded by Arjan van der Plaats and Professor Gerard Rakhorst

1998

XVIVO Perfusion founded and research collaboration initiated with Prof. Stig Steen.

Fill out the form to watch the video